Adam Woodrow, President & Chief Commercial at Paratek Pharmaceuticals, Inc. (PRTK), sold 62,616 shares at $4.27 ($269K) on 2021-12-15, disclosed to the SEC on 2021-12-15.
Seasonal sale ($269k) by President & Chief Commercial — this insider has traded PRTK in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.42 | 6,422 | $28K | 10.5% |
| 2 | $4.37 | 10,946 | $48K | 17.8% |
| 3 | $4.27 | 22,624 | $97K | 35.9% |
| 4 | $4.27 | 22,624 | $97K | 35.9% |
| Total | $4.30 avg | 62,616 | $269K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $16K | — | Filing → |
| PRTK | SELL | 2021-08-18 | $56K | — | Filing → |
| PRTK | SELL | 2021-06-08 | $333K | — | Filing → |